No Data
Express News | Multiple biomedical collaborations were reached during the Import Expo, involving multiple areas such as hepatitis B and women's health.
FDA recommends stopping the use of common decongestants in cold medicines, glaxosmithkline (GSK.US) and other companies may be affected.
The Food and Drug Administration (FDA) announced on Thursday that it has proposed to remove the oral phenylephrine commonly used in cold and cough syrups from the active ingredients of over-the-counter nasal decongestants and deemed it ineffective.
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
Pfizer, GSK, Moderna Struggle in a Shrinking RSV Vaccine Market
Express News | The USA FDA proposed to stop using the common decongestants in cold medicines.
No Data
No Data
